Medtech Insights

Although it will be negatively impacted in the short term by the COVID-19 pandemic, the European neurostimulation device market is growing modestly, and will be buoyed over the forecast period by…

The Asia Pacific market for PV devices will grow modestly through 2029, fueled by the growing PAD population and the adoption of premium devices like DCBs, DES, and powered thrombectomy…

The European market for heart valve devices will grow through 2029, fueled by an expanding aging population and rising adoption of THV devices, reflecting the accumulation of favorable clinical…

Compared to other major orthopedic markets, the Asia Pacific trauma device market will be somewhat less severely impacted by the COVID-19 pandemic given the urgent nature of many trauma cases…

Although the COVID-19 pandemic will have a negative impact on procedure volumes and market growth in 2020, the Asia Pacific market for structural heart closure devices will grow moderately in…

The European market for aortic repair devices will expand at a modest rate, driven primarily by endovascular procedure volume growth and continued development and adoption of aortic stent…

Although the European market for interventional oncology devices will be hindered in the immediate term by the impact of the COVID-19 pandemic, the market will be characterized by procedure…

The European market for aortic repair devices will expand at a modest rate, driven primarily by endovascular procedure volume growth and continued development and adoption of aortic stent…

The European market for TEO devices will be driven by adoption of innovative and premium-priced products, incremental device improvements, as well as rising penetration of endovascular…

The Latin American heart valve device market will experience robust growth through 2029, largely driven by an expanding patient pool, improving access to treatments, and rising adoption of THV…

The Asia Pacific market for aortic repair devices will expand at a moderate rate, driven primarily by endovascular procedure volume growth and continued development and adoption of aortic stent…

Although the Asia Pacific market for interventional oncology devices will be hindered in the immediate term by the impact of theCOVID-19pandemic, the market will expand rapidlythrough 2029, driven…